Answers are grounded in this paper and cite their sources.
Diabetes mellitus is a major global health challenge, and inhibition of carbohydrate-digesting enzymes is one strategy for controlling postprandial hyperglycaemia in type 2 diabetes. Allium cepa (onion) contains diverse phytochemicals, but their predicted enzyme-binding and drug-related properties remain poorly characterised. This study aimed to evaluate the predicted binding affinities and pharmacokinetic properties of selected Allium cepa phytochemicals against human pancreatic α-amylase (PDB ID: 1HNY) and lysosomal acid α-glucosidase (GAA; PDB ID: 5NN4), the latter used as a structural representative of the GH31 α-glucosidase family. A total of 181 reported phytochemicals were docked using AutoDock Vina in PyRx, with acarbose and miglitol as reference compounds, after validating the protocol by redocking (RMSD 1.14 and 1.20 Å). Top-ranked compounds were further assessed for ADMET properties (ADMETlab 3.0), drug-likeness and oral bioavailability (SwissADME), and predicted activity spectra (PASS). Daucosterol (−9.7 kcal/mol), quercetin (−8.6 kcal/mol), 2,3-dihydroflavon-3-ol, taxifolin, isorhamnetin: −8.5 kcal/mol scored better than acarbose (−6.5 kcal/mol) against α-amylase, while daucosterol (−8.2 kcal/mol) and quercetin (−7.9 kcal/mol) scored better than acarbose (−6.9 kcal/mol) against GAA. Hits interacted with catalytic-site residues, including Asp197, Glu233 and Asp300 of α-amylase. Most hits satisfied Lipinski’s rule with no more than one violation and showed acceptable predicted ADMET profiles, although daucosterol is large and poorly soluble. These are computational predictions only; molecular dynamics, in vitro enzyme assays, and testing against intestinal α-glucosidases (maltase-glucoamylase and sucrase-isomaltase) are recommended
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: